| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2124398 | European Journal of Cancer | 2009 | 9 Pages |
Abstract
Gemcitabine given by 24-h HAI was well tolerated and resulted in significantly lower systemic gemcitabine plasma concentrations than intravenous infusion due to a relatively high hepatic extraction.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
J.M. van Riel, G.J. Peters, L.H. Mammatas, R.J. Honeywell, A.C. Laan, R. Ruyter, F.G. van den Berg, G. Giaccone, C.J. van Groeningen,